Advanced search×

Pot1b Deletion and Telomerase Haploinsufficiency in Mice Initiate an ATR-Dependent DNA Damage Response and Elicit Phenotypes Resembling Dyskeratosis Congenita

Mol Cell Biol 29(1):229-240 (2008) PMID 18936156 PMCID PMC2612488

The Protection of telomeres 1 (POT1) protein is a single-stranded telomere binding protein that is essential for proper maintenance of telomere length. Disruption of POT1 function leads to chromosome instability and loss of cellular viability. Here, we show that targeted deletion of the mouse Pot1b gene results in increased apoptosis in highly proliferative tissues. In the setting of telomerase haploinsufficiency, loss of Pot1b results in depletion of germ cells and complete bone marrow failure due to increased apoptosis, culminating in premature death. Pot1b(-/-) mTR(+/-) hematopoietic progenitor and stem cells display markedly reduced survival potential in vitro. Accelerated telomere shortening, increased G overhang and elevated number of chromosome end-to-end fusions that initiate an ATR-dependent DNA damage response were also observed. These results indicate an essential role for Pot1b in the maintenance of genome integrity and the long-term viability of proliferative tissues in the setting of telomerase deficiency. Interestingly, these phenotypes closely resemble those found in the human disease dyskeratosis congenita (DC), an inherited syndrome characterized by bone marrow failure, hyperpigmentation, and nail dystrophy. We anticipate that this mouse will serve as a useful model to further understand the pathophysiology of DC.

DOI: 10.1128/MCB.01400-08
Version: za2963e q8zab q8zbf q8zc9 q8zdc q8zec q8zf9 q8zg2

Similar articles you may find interesting…

  1. Transforming Growth Factor-β induced cross talk between p53 and a microRNA in the pathogenesis of Diabetic Nephropathy.

    Diabetes (2013) PMID 23649518

    We report that expression levels of transforming growth factor-β1 (TGF-β), p53 and microRNA-192 (miR-192), are increased in the renal cortex of diabetic mice, and this is associated with enhanced glomerular expansion and fibrosis relative to non-diabetic mice. Targeting miR-192 with locked-nucleic...
  2. Exploring a neurogenic basis of velopharyngeal dysfunction in Tbx1 mutant mice: No difference in volumes of the nucleus ambiguus.

    Int J Pediatr Otorhinolaryngol (2013) PMID 23642587

    Based on the histology, there is no difference or variability between the volumes of the nucleus ambiguus of Tbx1 heterozygous and wild type mice. The etiology of velopharyngeal hypotonia and variable speech in children with 22q11.2 deletion syndrome warrants further investigation. C...
  3. Targeted Deletion of the Mouse α2 Nicotinic Acetylcholine Receptor Subunit Gene (Chrna2) Potentiates Nicotine-Modulated Behaviors.

    J Neurosci 33(18):7728-41 (2013) PMID 23637165

    Baseline and nicotine-modulated behaviors were assessed in mice harboring a null mutant allele of the nicotinic acetylcholine receptor (nAChR) subunit gene α2 (Chrna2). Homozygous Chrna2(-/-) mice are viable, show expected sex and Mendelian genotype ratios, and exhibit no gross neur...